Is tongxinluo more effective than isosorbide dinitrate in treating angina pectoris? A systematic review and meta-analysis of randomized controlled trials

Journal of Alternative and Complementary Medicine

Volumn 17, Issue 12, 2011, Pages 1109-1117

  Jia, Yongliang ^a,b   Bao, Feifei ^a,b   Huang, Fangyi ^c   Leung, Siu Wai ^a,b,d  

^a China jack1987168 163com   (Macao)

^b University of Macau   (Macao)

^c UNIVERSITY OF MACAU   (Macao)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; ISOSORBIDE DINITRATE; TONGXINLUO; UNCLASSIFIED DRUG;

ANGINA PECTORIS; CHINESE MEDICINE; COCHRANE LIBRARY; COMPARATIVE EFFECTIVENESS; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; ELECTROCARDIOGRAM; EPIGASTRIC DISCOMFORT; HUMAN; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY ANALYSIS; SKIN REDNESS; SYSTEMATIC REVIEW;

EID: 83655165044     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2010.0788     Document Type: Review

References (45)

1. Nomenclature and Criteria for Diagnosis of Ischemic Heart Disease. Report of the joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 1979;3:607-609.
2. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: Summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 2003;107:149-158. (Pubitemid 36070948)
3. Abrams J. Beneficial actions of nitrates in cardiovascular disease. Am J Cardiol 1996;77:31-37.
4. Chen WQ, Zhong L, Zhang L, et al. Chinese medicine Tongxinluo significantly lowers serum lipid levels and stabilizes vulnerable plaques in rabbit model. J Ethnopharma-col 2009;401:103-110.
5. Thadani U. Oral nitrates: More than symptomatic therapy in coronary artery disease? Cardiov Drug Ther 1997;11:213-218. (Pubitemid 27229316)
6. He SZ, Wu WK, Deng ZS, et al. Systematic review on randomized controlled trials for treatment of coronary heart disease by Tongxinluo capsule. J Sun Yat-sen Univ (Med Sci) 2007;28:572-576.
7. Chinese Pharmacopoeia Committee. Chinese Pharmacopoeia 2005 edition. Beijing: Chemical Industry Press, 2005.
8. Zhang L, Liu Y, Lu XT, et al. Traditional Chinese medication Tongxinluo dose-dependently enhances stability of vulnerable plaques: A comparison with a high-dose simvastatin therapy. Am J Physiol Heart Circ Physiol 2009;297:2004-2014.
9. Wang J. Yiling Group: Opening up the market of Chinese medicine by innovation. J Chin Drugstore 2010;4:124-126.
10. Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:698-672.
11. Wu TX, Roger H, Liu GJ, et al. A Cochrane systematic review protocol of Tongxinluo capsule for unstable angina pectoris. Chin J EBM 2003;3:26-33.
12. Wu T, Harrison RA, Chen X, et al. Tongxinluo (Tong xin luo or Tong-xin-luo) capsule for unstable angina pectoris. Co-chrane Database Syst Rev 2006;4:CD004474.
13. Hao CH, Zhang JY. Meta-analysis of Tongxinluo capsule for coronary heart disease angina. China Mode Doct 2010;48:6-9.
14. Moher D, Liberati A, Tetzlaff J, Altman DG, the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. PLoS Med 2009; 6:e1000097.
15. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996;17:1-12. (Pubitemid 26120810)
16. JTP Higgins, S Green. Cochrane Handbook for Systematic Reviews of Interventions. Chichester, UK: Wiley Online Library, 2008.
17. Geha RS, Schneeberger E, Merler E, Rosen FS. Heterogeneity of acquired or common variable agammaglobulinemia. NEJM 1974;291:1-6.
18. Leucht S, Wahlbeck K, Hamann J, Kissling W. New generation antipsychotics versus low-potency conventional anti-psychotics: A systematic review and meta-analysis. Lancet 2003;361:1581-1589. (Pubitemid 36578993)
19. Sterne JAC, Egger M. Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis. J Clin Epidemiol 2001;54:1046-1055. (Pubitemid 32888370)
20. Thompson SG, Higgins JPT. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002;21: 1559-1573. (Pubitemid 34746063)
21. Higgins JPT, Thompson SG. Controlling the risk of spurious findings from meta-regression. Stat Med 2004;23:1663-1682. (Pubitemid 38765338)
22. Chen WM, Yu CZ. Clinical study of coronary heart disease treated with Tongxinluo capsule. Mode Hosp 2006;6:57-58.
23. Gao YC, Guo JL, Wang S. Clinical observation 40 patients of Tongxinluo capsule treating coronary heart disease angina pectoris. Correspond J TCM 1998;17:26-27.
24. Hua J. Forty patients with angina pectoris treated with hollow wind capsule. J Henan M College Staff Workers 2008;20:569-570.
25. Kang JH, Guo LN, Li LM, et al. Effect of Tongxinluo capsule in treating stable angina pectoris. Chin J Pract Intern Med 2008;28:59-60.
26. Li J, Wang YZ. 52 patients of Tongxinluo capsule treating coronary heart disease angina. Shanxi J TCM 2003;24:103-104.
27. Li YY. Clinical observation 40 patients of Tongxinluo capsule treating angina pectoris. J Handan Med Col 2003;16:116.
28. Liu CH. Clinical observation of Tongxinluo capsule treating coronary heart disease angina. Hainan Med J 2006;17:74-75.
29. Peng M. Clinical observation 30 patients of Tongxinluo capsule in treatment of coronary heart disease angina pec-toris. J Guangdong Med Col 2001;19:296.
30. Qian XX, Chen YM, Liu Y, et al. Effect of Tongxinluo capsule on endothelial function instable angina pectoris patients. Chin J Pathophysiol 2006;22:1698-1701.
31. Shen K. Clinical analysis 80 patients of Tongxinluo capsule in treatment of coronary heart disease angina pectoris. Hebei Med J 2002;8:535-537.
32. Tang GX. The efficacy observation of Tongxinluo capsule treating angina coronary artery disease. J Huaihai Med 2002;20:341.
33. Wang DW, Zheng JF, Ma BW. Observation of 66 patients of Tongxinluo capsule in treatment of coronary heart disease angina pectoris. J Zhejiang Col TCM 2007;42:431.
34. Wang H. Clinical observation on 36 patients of stable angina treated with Tongxinluo capsule. Mod Diagn Treat 2005; 16:157-158.
35. Wu SQ. The clinical observation on Tongxinluo capsule treating angina coronary artery disease. J Liaoning Col TCM 2004;6:313-314.
36. Xu YF. The analysis of 40 patients of Tongxinluo capsule treating coronary artery disease angina. Clin J TCM 2002; 14:170-171.
37. Yu K. The clinical study on resistance of Tongxinluo capsule for the treatment of coronary heart disease. J Bethune Milit Med Col 2004;2:207-209.
38. Yu P. Curative effect of Tongxinluo capsule on the heart stroke resulted from coronary artery disease. Appl J Gen Pract 2007;5:325-326.
39. Zhang Q, Yang LH, Qiao P, Cui TX. Clinical observation of the effects of Tongxinluo capsule injection on 68 patients with unstable angina pectoris. Chin J Primary Med Pharm 2004;11:1080-1081.
40. Zhu ZT. Efficacy observation of Tongxinluo capsule treating the changes of myocardial ischemia bloody due to coronary heart disease. Chin J Infor TCM 2003;20:37.
41. Wang D, Bakhai A. Clinical Trials: A Practical Guide to Design, Analysis, and Reporting. London: Remedica, 2006.
42. Xu L, Li J, Zhang M, et al. Chinese authors do need CONSORT: Reporting quality assessment for five leading Chinese medical journals. Contemp Clin Trials 2008;29:727-731.
43. Wu TX, Li YP, Bian ZX, et al. Randomized trials published in some Chinese journals: How many are randomized? Trials 2009;10:46.
44. Wang G, Mao B, Xiong ZY, et al. CONSORT Group for Traditional Chinese Medicine: The quality of reporting of randomized controlled trials of traditional Chinese medicine. A survey of 13 randomly selected journals from mainland China. Clin Ther 2007;29:1456-1467. (Pubitemid 47348121)
45. Zhang DL, Yin P, Freemantle N, et al. An assessment of the quality of randomized controlled trials conducted in China. Trials 2008;9:22.